Home NAD+ and PT-141
Give NAD+ and PT-141 their own explanations
NAD+ and PT-141 may turn up in the same wellness conversation, but they’re different subjects. NAD+ appears in claims about energy and aging. PT-141 is another name for bremelanotide, which has an approved sexual-health use. I’d give each its own explanation.
NAD+ is not a peptide
NAD+ is a coenzyme, a helper in chemical reactions inside cells, including making usable energy. That essential job doesn’t prove a benefit from taking more. A review of human research on NAD+ precursors found limited benefits. Precursors are substances the body can use to make NAD+.
One precursor is nicotinamide riboside, or NR. A trial of oral NR found that it raised blood NAD+. That’s a blood measurement, not evidence that people lived longer. It also doesn’t tell us what an infusion of NAD+ would do.
Safety needs its own attention. The small infusion-record review is about how infusions were tolerated, not whether they extend life. Looking back at a limited set of records leaves long-term safety unanswered. I’d keep that limit in mind before treating an anti-aging claim as established.
PT-141 has a particular job
Bremelanotide has an FDA-approved injection for acquired, generalized hypoactive sexual desire disorder—distressing low sexual desire—in women who haven’t reached menopause. A change in desire isn’t enough on its own to settle whether that diagnosis fits. I’d leave that question to a clinician who can check the label’s full criteria. The label describes the approved use and its limits. It isn’t approved for men, women after menopause, or improving sexual performance.
Two trials found improvements in desire and related distress compared with placebo, a treatment without the active medicine. That finding applies to the women studied. A research-use preparation called PT-141 doesn’t share the approved product’s status.
Two names, two different conversations
I’d take a personal sexual-health concern to a licensed clinician, with room to discuss other explanations. For NAD+, I’d ask what benefit in people supports the exact preparation being discussed. The care questions help get those conversations ready. You don’t need to arrive already convinced that either substance is the answer.